Harbour Investments Inc. Has $779,000 Position in Leidos Holdings, Inc. $LDOS

Harbour Investments Inc. boosted its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 5,363.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,316 shares of the aerospace company’s stock after buying an additional 4,237 shares during the quarter. Harbour Investments Inc.’s holdings in Leidos were worth $779,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JFS Wealth Advisors LLC raised its position in shares of Leidos by 77.6% in the 4th quarter. JFS Wealth Advisors LLC now owns 151 shares of the aerospace company’s stock worth $27,000 after acquiring an additional 66 shares in the last quarter. Hantz Financial Services Inc. raised its position in shares of Leidos by 94.7% in the 4th quarter. Hantz Financial Services Inc. now owns 148 shares of the aerospace company’s stock worth $27,000 after acquiring an additional 72 shares in the last quarter. Rakuten Securities Inc. raised its position in shares of Leidos by 110.5% in the 4th quarter. Rakuten Securities Inc. now owns 160 shares of the aerospace company’s stock worth $29,000 after acquiring an additional 84 shares in the last quarter. Cape Investment Advisory Inc. bought a new position in shares of Leidos in the 3rd quarter worth about $31,000. Finally, Wexford Capital LP bought a new position in shares of Leidos in the 3rd quarter worth about $32,000. 76.12% of the stock is owned by institutional investors and hedge funds.

Leidos Stock Performance

Shares of Leidos stock opened at $127.93 on Friday. Leidos Holdings, Inc. has a one year low of $121.20 and a one year high of $205.77. The firm has a market capitalization of $16.09 billion, a price-to-earnings ratio of 11.72, a PEG ratio of 1.62 and a beta of 0.56. The business has a 50-day simple moving average of $144.95 and a 200 day simple moving average of $170.99. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.40 and a quick ratio of 1.29.

Leidos (NYSE:LDOS) last issued its earnings results on Tuesday, May 5th. The aerospace company reported $3.13 EPS for the quarter, beating analysts’ consensus estimates of $2.88 by $0.25. Leidos had a return on equity of 31.92% and a net margin of 8.15%.The business had revenue of $4.40 billion during the quarter, compared to analyst estimates of $4.28 billion. During the same period in the previous year, the company posted $2.97 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. On average, research analysts anticipate that Leidos Holdings, Inc. will post 12.25 earnings per share for the current fiscal year.

Leidos Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be given a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Monday, June 15th. Leidos’s payout ratio is presently 15.75%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on LDOS shares. BNP Paribas Exane started coverage on Leidos in a research report on Wednesday. They issued an “outperform” rating and a $165.00 price objective for the company. Truist Financial lowered their price objective on Leidos from $220.00 to $195.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Wall Street Zen raised Leidos from a “hold” rating to a “buy” rating in a research report on Sunday, May 24th. Citigroup lowered their price objective on Leidos from $232.00 to $178.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Finally, Royal Bank Of Canada lowered their price objective on Leidos from $215.00 to $180.00 and set an “outperform” rating for the company in a research report on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $191.25.

Insider Transactions at Leidos

In related news, Director Gary Stephen May sold 1,484 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $132.75, for a total value of $197,001.00. Following the completion of the sale, the director directly owned 10,137 shares of the company’s stock, valued at $1,345,686.75. The trade was a 12.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Elizabeth A. Porter sold 2,000 shares of the business’s stock in a transaction dated Tuesday, April 7th. The shares were sold at an average price of $158.78, for a total value of $317,560.00. Following the completion of the sale, the insider directly owned 49,476 shares of the company’s stock, valued at $7,855,799.28. The trade was a 3.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.77% of the company’s stock.

About Leidos

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.